The Wearables in Pharma & Biotech Market is projected to nearly triple in size, growing from $3.98 billion in 2026 to $9.97 billion by 2031, with a compound annual growth rate (CAGR) of 20.2%. The market is being driven by the increasing adoption of wearables for clinical trials and patient monitoring, particularly in managing chronic diseases like diabetes. North America currently leads in market share due to its adoption of connected health technologies and supportive reimbursement policies. Key companies in the sector include Abbott, Apple, and Medtronic. The rise of decentralized clinical trials is enhancing the efficiency of data collection and patient engagement in research.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://finance.yahoo.com/sectors/healthcare/articles/wearables-pharma-biotech-market-worth-143100799.html
